GN0M.DE vs. EXV4.DE
GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) and EXV4.DE (iShares STOXX Europe 600 Health Care UCITS ETF (DE)) are both Health & Biotech Equities funds - GN0M.DE tracks the Solactive Genomics while EXV4.DE tracks the STOXX® Europe 600 Health Care. Both are passively managed. Over the past 3 years, GN0M.DE returned -1.90%/yr vs 2.32%/yr for EXV4.DE. At a 0.42 correlation, their price movements are largely independent. GN0M.DE charges 0.50%/yr vs 0.46%/yr for EXV4.DE.
Performance
GN0M.DE vs. EXV4.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than EXV4.DE's -2.60% return.
GN0M.DE
- 1D
- 5.61%
- 1M
- 11.50%
- YTD
- 12.99%
- 6M
- 9.82%
- 1Y
- 55.73%
- 3Y*
- -1.90%
- 5Y*
- —
- 10Y*
- —
EXV4.DE
- 1D
- 2.82%
- 1M
- 0.11%
- YTD
- -2.60%
- 6M
- -1.19%
- 1Y
- 4.38%
- 3Y*
- 2.32%
- 5Y*
- 4.98%
- 10Y*
- 5.78%
GN0M.DE vs. EXV4.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 12.99% | 5.67% | -12.40% | -9.04% | -32.50% | -7.90% |
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | -2.60% | 7.23% | 3.85% | 7.52% | -6.10% | 1.11% |
Correlation
The correlation between GN0M.DE and EXV4.DE is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Nov 12, 2021 | 0.42 |
The correlation between GN0M.DE and EXV4.DE shifts across timeframes, from 0.41 (3 years) to 0.52 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GN0M.DE vs. EXV4.DE — Risk / Return Rank
GN0M.DE
EXV4.DE
GN0M.DE vs. EXV4.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GN0M.DE | EXV4.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.71 | ||
| Sortino ratioReturn per unit of downside risk | +2.28 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.06 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 3.32 | 0.38 | +2.94 |
| Martin ratioReturn relative to average drawdown | 8.35 | 0.84 | +7.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GN0M.DE | EXV4.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.00 | 0.29 | +1.71 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.32 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.37 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.34 | 0.32 | -0.66 |
Drawdowns
GN0M.DE vs. EXV4.DE - Drawdown Comparison
The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than EXV4.DE's maximum drawdown of -44.54%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and EXV4.DE.
Loading charts...
Drawdown Indicators
| GN0M.DE | EXV4.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.19% | -44.54% | -22.65% |
Max Drawdown (1Y)Largest decline over 1 year | -16.68% | -12.57% | -4.11% |
Max Drawdown (3Y)Largest decline over 3 years | -48.19% | -26.55% | -21.64% |
Max Drawdown (5Y)Largest decline over 5 years | — | -26.55% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.55% | — |
Current DrawdownCurrent decline from peak | -41.03% | -11.65% | -29.38% |
Average DrawdownAverage peak-to-trough decline | -43.13% | -11.17% | -31.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.65% | 5.72% | +0.93% |
Volatility
GN0M.DE vs. EXV4.DE - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) at 5.58%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than EXV4.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GN0M.DE | EXV4.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.15% | 5.58% | +2.57% |
Volatility (6M)Calculated over the trailing 6-month period | 19.69% | 11.86% | +7.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.68% | 16.68% | +11.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.49% | 15.55% | +15.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.49% | 15.74% | +15.75% |
GN0M.DE vs. EXV4.DE - Expense Ratio Comparison
GN0M.DE has a 0.50% expense ratio, which is higher than EXV4.DE's 0.46% expense ratio.
Dividends
GN0M.DE vs. EXV4.DE - Dividend Comparison
GN0M.DE has not paid dividends to shareholders, while EXV4.DE's dividend yield for the trailing twelve months is around 1.61%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 1.61% | 1.58% | 1.45% | 1.60% | 1.59% | 1.47% | 1.24% | 1.79% | 1.85% | 2.64% | 2.90% | 2.60% |
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
GN0M.DE and EXV4.DE have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, EXV4.DE is cheaper at 0.46% per year. The better choice depends on whether you care most about return, fees, risk, or income.
EXV4.DE is cheaper with a 0.46% expense ratio, compared with 0.50% for GN0M.DE.
GN0M.DE tracks Solactive Genomics, while EXV4.DE tracks STOXX® Europe 600 Health Care. They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for GN0M.DE and 0.46% for EXV4.DE.
Find the right allocation for GN0M.DE and EXV4.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer